As expected, we found higher insulin resistance and area under the curve (AUC) for glucose and insulin, and lower insulin sensitivity and β-cell function, as assessed by insulin secretion-sensitivity index, in women diagnosed with GDM at weeks 14–16 and 30–32 (Table 1). The gene discussed is INS; the disease is gestational diabetes.